Comparison 23. Topical calcineurin inhibitors: tacrolimus 0.1% ointment versus vehicle.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Primary: investigator‐rated good/excellent control of symptoms	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
2 Primary: adverse events burning/itching at application site	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
2.1 Burning/itching at application site	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]